为了改善聚3-基酸盐的西洛代谢的多维工程,在复合大肠杆菌中从玉米水解盐中合成了复合大肠杆菌
Dong Meng1, Shuai Wang1, Ke Zhao2
1Key Laboratory of Medical Molecule Science and Pharmaceutical Engineering, Ministry of Industry and Information Technology, Institute of Biochemical Engineering, Department of Chemical Engineering, School of Chemistry and Chemical Engineering, Beijing Institute of Technology, Beijing 100081, China.
Journal of agricultural and food chemistry
|August 4, 2025
概括
工程化大肠杆菌高效地共同利用玉米炉水解盐中的葡萄糖和西洛斯,用于生产聚乙酸 (PHB). 这种增强的微生物菌株产生了显著更多的PHB,其物理性质得到了改善.
科学领域:
- 生物技术是生物技术.
- 代谢工程是代谢工程.
- 聚合物科学 聚合物科学
背景情况:
- 主要由葡萄糖和西洛斯组成的纤维素,对高效的生物生产提出了挑战.
- 提高这些糖的共同利用对于提高生物工艺效率至关重要.
- 玉米炉水解剂 (CSH) 是微生物生产的有前途,丰富且具有成本效益的原料.
研究的目的:
- 设计一种能够有效地从CSH中共同利用葡萄糖和西洛斯的*Escherichia coli*菌株.
- 为了优化代谢途径,增强碳流向聚3-基酸盐 (PHB) 合成.
- 评估使用工程菌株从CSH合成的PHB的生产和特性.
主要方法:
- 消除碳催化剂抑制以克服葡萄糖抑制西洛斯代谢.
- 优化关键基因 (*tktA*, *xylB*) 的表达,以促进西洛斯的代谢流量.
- 向氧化糖异质酶到周等离子体,以减少代谢交叉和改善氧化糖的同化.
主要成果:
- 工程系AM28菌株显示,从CSH中增强了酶利用率和乙烯-CoA衍生物合成.
- 菌株AM28 (phaCAB) 产生了3.2g/LPHB,从CSH获得的产量为0.15g/g,显著优于对照菌株.
- 由工程菌株产生的PHB表现出更好的结晶性,热稳定性和分子重量.
结论:
- 改造的*大肠杆菌*菌株显示出强大的能力,能够从CSH中共同利用葡萄糖和西洛斯.
- 这种代谢工程方法可以高效地生产具有优越材料特性的PHB.
- 该研究为利用CSH用于可持续PHB合成提供了有价值的见解.
相关概念视频
Biosynthesis of Polysaccharides
Polysaccharides such as glycogen and starch are synthesized from nucleoside diphosphate sugars, primarily uridine diphosphate glucose (UDPG) and adenosine diphosphate glucose (ADPG). These activated glucose donors act as key intermediates in carbohydrate metabolism and biosynthesis. UDPG primarily involves glycogen synthesis in animals and many bacteria, while ADPG plays a fundamental role in starch synthesis in plants and certain bacteria.UDPG is formed when glucose-1-phosphate reacts with...
Bioreactor Controls-III
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
Upstream Processing
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
Production of Alcohol
Continuous fermentation is a key strategy in industrial ethanol production, particularly when efficiency, scalability, and high yields are essential. This approach allows for uninterrupted operation and optimized resource utilization. The primary feedstock, corn starch, undergoes enzymatic hydrolysis facilitated by α-amylase and glucoamylase. These enzymes break down the starch into fermentable sugars such as glucose, which are readily assimilated by fermentative microorganisms.Fermentation...
Production of Organic Acids
Lactic acid, an important organic acid extensively applied in food, pharmaceutical, and biodegradable polymer industries, is primarily produced via microbial fermentation. This method is favored over chemical synthesis due to its environmental sustainability and capacity for enantiomerically pure product formation. Among various microbial processes, the fermentation of starch-based substrates stands out due to the abundance and renewability of raw materials like corn and potatoes.Hydrolysis of...
Production of Pharmaceuticals
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...


